|
Julie Morris. How to critique a paper |
|
|
105 |
Discussion. Plan an agenda for the next
station. |
|
106 |
Role-play. BRCA1 carrier. Risk
reduction. |
This has
come in OSCE exams, though usually with a preparatory station. Some new variant
may be created for the Part 3 and a good technique for rapid assessment of a
paper will be essential..
There was
a recent paper in the BJOG by Gaba et al about the attitudes of women who are
BRCA carriers to risk-reducing surgery. It is open access, so I have added it
to the papers for today’s tutorial on Dropbox. You can also download it from
the internet.
https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.16424.
When I
read it, I realised that it would have triggered me to write a station for the
exam had I been an examiner and would also be a good basis for an exercise in
creating an agenda for a station. How are you going to really impress an
examiner?
This is
the logical follow-on – put the above agenda into action.
Candidate’s instructions.
You are an SpR5 in the gynaecology clinic and about to
see Jessica Green. DOB 1 January 1990.
Your tasks are to take an appropriate history and discuss
the options available to her.
GP letter.
The Surgery,
Main Road,
Anytown.
Re: Jessica Green, 25 Blether Alley, Anytown.
Dear Gynaecologist,
Please see this charming young lady.
Dr. Rosemary Ique, my very clever young colleague, saw her last
year to discuss management of anaemia and heavy periods. There was good
response to the use of a Mirena and some iron pills, but clever Dr. Rosemary
elicited a family history of cancer and referred her to the regional Familial
Genetic Cancer clinic and it turns out that she is a carrier of an oncogenic
BRCA mutation. All of this is quite new to me, I must say, and I suspect that I
might not have sparked to the importance of the family history, or even
uncovered it! There was some discussion of her options to reduce her risk of
cancer and she would very much like to explore these further.
I look forward to hearing your thoughts.
Dr. John Worthy.
No comments:
Post a Comment